HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Mylan announces U.S. launch of generic AXERT tablets

Mylan N.V. today announced the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical's AXERT.

17 Nov 2015

New US bipartisan study advocates promoting global health to advance wide range of American interests

A new US bipartisan study advocates promoting global health to both "do the right thing" and advance wide-ranging foreign policy interests.

17 Nov 2015

Public policy needed to reduce stem cell tourism, say experts

The continued marketing and use of experimental stem cell-based interventions inside and outside the United States is problematic and unsustainable, according to a new paper by science policy and bioethics experts at Rice University's Baker Institute for Public Policy and Wake Forest University.

10 Nov 2015

EGPAF, EJAF launch new project to expand HIV treatment, prevention efforts for adolescents in Africa

The Elizabeth Glaser Pediatric AIDS Foundation and the Elton John AIDS Foundation today launched a new project to expand HIV treatment and prevention efforts for adolescents in urban settings in Kenya and Zambia.

10 Nov 2015

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Hot flashes. Night sweats. These are the most common - or at least the most commonly talked about - symptoms of menopause. But one reality of The Change for many women is less discussed yet no less important: problems with vaginal health and sexual function.

6 Nov 2015

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

Mylan N.V. today announced the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company plc subject to Mylan's divestiture of certain products following the consummation of the offer.

4 Nov 2015

Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack.

31 Oct 2015

Specialized type of immunotherapy can boost survival from pancreatic cancer

A new study in mice by researchers at Fred Hutchinson Cancer Research Center has found that a specialized type of immunotherapy — even when used without chemotherapy or radiation — can boost survival from pancreatic cancer, a nearly almost-lethal disease, by more than 75 percent. The findings are so promising, human clinical trials are planned within the next year.

30 Oct 2015

Despite reduced HIV/AIDS deaths, disease still persists in South Africa

After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.

30 Oct 2015

Mylan announces U.S. launch of generic Fusilev for Injection

Mylan N.V. today announced the U.S. launch of Levoleucovorin Calcium Injection 10 mg (base)/mL; 175 mg (base)/17.5 mL and 250 mg (base)/25 mL Single-use Vials, which is the generic version of Spectrum Pharmaceuticals' Fusilev for Injection.

27 Oct 2015

New research may have profound impact on future development of anti-depressant medications

Major depression, which afflicts one in six people at some point in their life, is the leading global cause of disability - surpassing cardiovascular and respiratory diseases, cancer and HIV/AIDS combined.

22 Oct 2015

Researchers use cutting edge genomic methods to explain protective effects of malaria vaccine candidate

An international team led by researchers from the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health, and Fred Hutchinson Cancer Research Center have used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world's most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S).

22 Oct 2015

Pitt Public Health launches study to promote health among aging gay and bisexual men with HIV

As the U.S. reaches an important milestone this year in the fight against HIV with more than half the people living with the virus older than age 50, the University of Pittsburgh Graduate School of Public Health is launching a study to determine ways to promote health among aging gay and bisexual men, who make up about two-thirds of the people aging with HIV.

22 Oct 2015

New study finds high prevalence of HIV among pregnant refugee women in Ontario

Pregnant refugee women in Ontario have a higher prevalence of HIV than immigrants and Canadian-born women, a new study examining serious pregnancy and delivery complications has found.

20 Oct 2015

Rutgers School of Nursing takes lead in $6 million nationwide effort to prevent new HIV infections

Rutgers School of Nursing is taking the lead in a $6 million nationwide effort to greatly reduce new HIV infections - a battle complicated by both the aging of career HIV health care professionals and a failure to engage all people living with HIV into treatment.

19 Oct 2015

Get your flu shot before fall festivities, says Loyola infectious disease specialist

While planning your family's fall festivities this month, add the flu shot to the list. Then follow through with a visit to your doctor to make sure everyone is protected for the flu season. October is the recommended month to receive the vaccine for your best shot at preventing the flu.

13 Oct 2015

Federal judge grants permanent injunction against South Dakota medical laser manufacturer

A federal judge in the U.S. District Court for the District of South Dakota yesterday granted the U.S. Food and Drug Administration a permanent injunction against 2035 Inc. and Robert "Larry" Lytle, doing business as QLasers PMA and 2035 PMA.

12 Oct 2015

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy manufacturing, and Benitec Biopharma, a clinical stage biotechnology company commercializing a patented gene-silencing technology, DNA-directed RNA interference (ddRNAi), today announced that they have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process for Benitec's ddRNAi-based, Adeno-Associated Virus (AAV)-delivered products intended for therapeutic use in humans.

7 Oct 2015

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Luminex Corporation today announced that it has received FDA clearance for the company's ARIES® System and ARIES HSV 1&2 Assay.

7 Oct 2015

WHO and UNAIDS develop new standards to help countries improve quality of adolescent care

New Global Standards for quality health-care services for adolescents developed by WHO and UNAIDS aim to help countries improve the quality of adolescent health care.

6 Oct 2015

HIV/AIDS News and Research

Further Reading

Mylan announces U.S. launch of generic AXERT tablets

New US bipartisan study advocates promoting global health to advance wide range of American interests

Public policy needed to reduce stem cell tourism, say experts

EGPAF, EJAF launch new project to expand HIV treatment, prevention efforts for adolescents in Africa

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

Specialized type of immunotherapy can boost survival from pancreatic cancer

Despite reduced HIV/AIDS deaths, disease still persists in South Africa

Mylan announces U.S. launch of generic Fusilev for Injection

New research may have profound impact on future development of anti-depressant medications

Researchers use cutting edge genomic methods to explain protective effects of malaria vaccine candidate

Pitt Public Health launches study to promote health among aging gay and bisexual men with HIV

New study finds high prevalence of HIV among pregnant refugee women in Ontario

Rutgers School of Nursing takes lead in $6 million nationwide effort to prevent new HIV infections

Get your flu shot before fall festivities, says Loyola infectious disease specialist

Federal judge grants permanent injunction against South Dakota medical laser manufacturer

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

WHO and UNAIDS develop new standards to help countries improve quality of adolescent care

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News